The decision how and when to invest in RD in China is a strategic choice. By investing more heavily and in more complex areas of RD in China, an MPC can signal its commitment to the Chinese market and strengthen relationships with key opinion leaders and officials there -- thus increasing its chances of thriving in the health care market now taking shape in China.